2023
DOI: 10.3390/medicina59061145
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of CD56, ADAM17 and FGF21 Expressions in the Placentas of Preeclampsia Cases

Abstract: Objective: In the present study, we investigated the expression of CD56, ADAM17 and FGF21 antibodies (Ab), which we think have an effect on the pathophysiology of preeclampsia (PE), in pregnant patients with healthy placentas and placentas with PE. The expression of these antibodies has been investigated in a limited amount of former research, but their role in PE has not yet been clarified. With this study, we aimed to contribute to the elucidation of the pathophysiology of PE and the detection of new target … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 39 publications
(78 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?